|
DE102018103278A1
|
|
A computer program, system and method for managing patient-related medical data
|
|
WO2011050981A2
|
|
Method for detecting balanced chromosomal aberrations in a genome
|
|
WO2006048263A2
|
|
Gene expression profiling in acute promyelocytic leukemia
|
|
WO2006048270A2
|
|
Methods of detecting leukemia and its subtypes
|
|
WO2006048264A2
|
|
Gene expression profiling in acute lymphoblastic leukemia (all), biphenotypic acute leukemia (bal), and acute myeloid leukemia (aml) m0
|
|
WO2006048266A2
|
|
Gene expression profiling of leukemias with mll gene rearrangements
|
|
WO2005045438A2
|
|
METHOD FOR DISTINGUISHING AML SUBTYPE INV(3)(q21q26)/t(3;3)(q21q26) FROM OTHER AML SUBTYPES
|
|
US2007212687A1
|
|
Method For Distinguishing Mll-Ptd-Positive Aml From Other Aml Subtypes
|
|
US2007212688A1
|
|
Method For Distinguishing Cbf-Positive Aml Subtypes From Cbf-Negative Aml Subtypes
|
|
WO2005045434A2
|
|
Method for distinguishing aml subtypes with recurring genetic aberrations
|
|
US2007148648A1
|
|
Method for distinguishing who classified aml subtypes
|
|
WO2005045437A2
|
|
Method for distinguishing immunologically defined all subtypes
|
